ea0059p174 | Obesity & metabolism | SFEBES2018
Yang Liu
, Aldhous Marian
, Chiswick Carolyn
, Norman Jane
, Denison Fiona
, Drake Amanda
, Reynolds Rebecca
Background: Metformin is widely used for treatment of gestational diabetes mellitus. Metformin is considered safe in pregnancy but crosses the placenta. The limited available data of follow-up of children exposed to metformin in utero suggests potential for increased adiposity but mechanisms are unknown. As placental DNA methylation has been linked to later obesity and metformin causes global DNA methylation changes in cancer cell lines we hypothesised that this may be a candi...